172 related articles for article (PubMed ID: 26583436)
1. Impact of postoperative nausea and vomiting prophylaxis with dexamethasone on the risk of recurrence of endometrial cancer.
Merk BA; Havrilesky LJ; Ehrisman JA; Broadwater G; Habib AS
Curr Med Res Opin; 2016; 32(3):453-8. PubMed ID: 26583436
[TBL] [Abstract][Full Text] [Related]
2. The impact of postoperative nausea and vomiting prophylaxis with dexamethasone on postoperative wound complications in patients undergoing laparotomy for endometrial cancer.
Bolac CS; Wallace AH; Broadwater G; Havrilesky LJ; Habib AS
Anesth Analg; 2013 May; 116(5):1041-1047. PubMed ID: 23337415
[TBL] [Abstract][Full Text] [Related]
3. Postoperative hyperglycemia after 4- vs 8-10-mg dexamethasone for postoperative nausea and vomiting prophylaxis in patients with type II diabetes mellitus: a retrospective database analysis.
Low Y; White WD; Habib AS
J Clin Anesth; 2015 Nov; 27(7):589-94. PubMed ID: 26303274
[TBL] [Abstract][Full Text] [Related]
4. Single dose of dexamethasone is not associated with postoperative recurrence and mortality in breast cancer patients: a propensity-matched cohort study.
Kim MH; Kim DW; Park S; Kim JH; Lee KY; Hwang J; Yoo YC
BMC Cancer; 2019 Mar; 19(1):251. PubMed ID: 30894164
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone prophylaxis of nausea and vomiting after epidural morphine for post-Cesarean analgesia.
Wang JJ; Ho ST; Wong CS; Tzeng JI; Liu HS; Ger LP
Can J Anaesth; 2001 Feb; 48(2):185-90. PubMed ID: 11220429
[TBL] [Abstract][Full Text] [Related]
6. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
7. A retrospective evaluation of the perioperative drug use and comparison of its cost in robotic vs open surgery for endometrial cancer.
Agarwal R; Rajanbabu A; Unnikrishnan UG
J Robot Surg; 2018 Dec; 12(4):665-672. PubMed ID: 29569172
[TBL] [Abstract][Full Text] [Related]
8. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
9. Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial.
Clemons M; Bouganim N; Smith S; Mazzarello S; Vandermeer L; Segal R; Dent S; Gertler S; Song X; Wheatley-Price P; Dranitsaris G
JAMA Oncol; 2016 Feb; 2(2):225-31. PubMed ID: 26562292
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival.
Ly D; Rowley BD; Dodson MK; Soisson PA; Jolles CJ; Gaffney DK; Sause WT
Gynecol Oncol; 2014 May; 133(2):250-5. PubMed ID: 24589416
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone and perioperative blood glucose in patients undergoing total joint arthroplasty: A retrospective study.
Nurok M; Cheng J; Romeo GR; Vecino SM; Fields KG; YaDeau JT
J Clin Anesth; 2017 Feb; 37():116-122. PubMed ID: 28235499
[TBL] [Abstract][Full Text] [Related]
13. Is dexamethasone associated with recurrence of ovarian cancer?
De Oliveira GS; McCarthy R; Turan A; Schink JC; Fitzgerald PC; Sessler DI
Anesth Analg; 2014 Jun; 118(6):1213-8. PubMed ID: 24299930
[TBL] [Abstract][Full Text] [Related]
14. Infection after urogynecologic surgery with the use of dexamethasone for nausea prophylaxis.
Gali B; Burkle CM; Klingele CJ; Schroeder D; Jankowski CJ
J Clin Anesth; 2012 Nov; 24(7):549-54. PubMed ID: 23101769
[TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study.
Helpman L; Perri T; Lavee N; Hag-Yahia N; Chariski HA; Kalfon S; Derazne E; Beiner ME; Kadan Y; Fishman A; Korach J; Covens A; Gien L
Int J Gynecol Cancer; 2019 Jan; 29(1):133-139. PubMed ID: 30640695
[TBL] [Abstract][Full Text] [Related]
16. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
17. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
18. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
19. Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: randomised double blind multicentre trial.
Wallenborn J; Gelbrich G; Bulst D; Behrends K; Wallenborn H; Rohrbach A; Krause U; Kühnast T; Wiegel M; Olthoff D
BMJ; 2006 Aug; 333(7563):324. PubMed ID: 16861255
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
